Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8887)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2014 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang XY, Yang F, Jin C, Fu DL. Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer. World J Gastroenterol 2014; 20(42): 15580-15589 [PMID: 25400441 DOI: 10.3748/wjg.v20.i42.15580] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i42/15580.htm |
| Number | Citing Articles |
| 1 |
Sarah Heiler, Zhe Wang, Margot Zöller. Pancreatic cancer stem cell markers and exosomes - the incentive push. World Journal of Gastroenterology 2016; 22(26): 5971-6007 doi: 10.3748/wjg.v22.i26.5971
|
| 2 |
Dongsheng Xu, You Zhang, Wei Huang, Xinbing Pan, Shuxian An, Cheng Wang, Gang Huang, Jianjun Liu, Weijun Wei. ImmunoPET imaging of EpCAM in solid tumours with nanobody tracers: a preclinical study. European Journal of Nuclear Medicine and Molecular Imaging 2024; doi: 10.1007/s00259-024-06910-8
|
| 3 |
Timothy Gilbert, Ryan Baron, Paula Ghaneh, Christopher Halloran. Pancreatic Cancer. 2016; : 1 doi: 10.1007/978-1-4939-6631-8_80-1
|
| 4 |
Kirstin A. Zettlitz, Wen-Ting K. Tsai, Scott M. Knowles, Naoko Kobayashi, Timothy R. Donahue, Robert E. Reiter, Anna M. Wu. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti–Prostate Stem Cell Antigen Cys-Diabody. Journal of Nuclear Medicine 2018; 59(9): 1398 doi: 10.2967/jnumed.117.207332
|
| 5 |
|
| 6 |
Kyuran Ann Choe, Nicholas M. McDonald. Multimodality Management of Borderline Resectable Pancreatic Cancer. 2016; : 17 doi: 10.1007/978-3-319-22780-1_2
|
| 7 |
Eyas Mohamed, Alexander Needham, Eftychia Psarelli, Melvyn Carroll, Sobhan Vinjamuri, Bal Sanghera, Wai Lup Wong, Christopher Halloran, Paula Ghaneh. Prognostic value of 18FDG PET/CT volumetric parameters in the survival prediction of patients with pancreatic cancer. European Journal of Surgical Oncology 2020; 46(8): 1532 doi: 10.1016/j.ejso.2020.02.002
|
| 8 |
Gerard M. Healy, C. E. Redmond, S. Murphy, H. Fleming, A. Haughey, R. Kavanagh, N. Swan, K. C. Conlon, D. E. Malone, E. R. Ryan. Preoperative CT in patients with surgically resectable pancreatic adenocarcinoma: does the time interval between CT and surgery affect survival?. Abdominal Radiology 2018; 43(3): 620 doi: 10.1007/s00261-017-1254-9
|
| 9 |
|
| 10 |
Omali Pitiyarachchi, John Kokkinos, George Sharbeen, Phoebe A. Phillips, Robert C. Gandy, Koroush S. Haghighi, Daniel A. Moses, Stephen R. Thompson, Jessica A.L. Borbasi, Rebecca Strutt, David Goldstein. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 386 doi: 10.1002/9781119756422.ch20
|
| 11 |
Asha Kandathil, Rathan M. Subramaniam. Imaging Diagnostics in Pancreatic Cancer. Clinical Gastroenterology 2021; : 89 doi: 10.1007/978-3-030-69940-6_5
|
| 12 |
Søren Hess, Ole Steen Bjerring, Per Pfeiffer, Poul Flemming Høilund-Carlsen. Personalized Clinical Decision Making in Gastrointestinal Malignancies. PET Clinics 2016; 11(3): 273 doi: 10.1016/j.cpet.2016.02.005
|
| 13 |
H. Duan, L. Baratto, R. Laudicella, F. Stracuzzi, S. Baldari, A. Iagaru. Molecular imaging of pancreatic neoplasms. Clinical and Translational Imaging 2021; 9(2): 141 doi: 10.1007/s40336-020-00408-7
|
| 14 |
Wen-Wen Sun, Zhi-Hong Xu, Chao-Fu Wang, Fang Wu, Jiu-Mei Cao, Pei-Jing Cui, Wei Huang, Xiao-Long Jin, Biao Li, Ke-Min Chen, Bei-Li Gao, Jia-An Hu. Pulmonary enteric adenocarcinoma with pancreatic metastasis: A case report. Oncology Letters 2017; 13(6): 4651 doi: 10.3892/ol.2017.6060
|
| 15 |
Ilaria Pergolini, Stefano Crippa, Matteo Salgarello, Giulio Belfiori, Stefano Partelli, Giacomo Ruffo, Alessandro Pucci, Giuseppe Zamboni, Massimo Falconi. SUVmax after (18)fluoro-deoxyglucose positron emission tomography/computed tomography: A tool to define treatment strategies in pancreatic cancer. Digestive and Liver Disease 2018; 50(1): 84 doi: 10.1016/j.dld.2017.09.122
|
| 16 |
Wungki Park, Akhil Chawla, Eileen M. O’Reilly. Pancreatic Cancer. JAMA 2021; 326(9): 851 doi: 10.1001/jama.2021.13027
|
| 17 |
Siqi Li, Huiyan Jiang, Zhiguo Wang, Guoxu Zhang, Yu-dong Yao. An effective computer aided diagnosis model for pancreas cancer on PET/CT images. Computer Methods and Programs in Biomedicine 2018; 165: 205 doi: 10.1016/j.cmpb.2018.09.001
|
| 18 |
Shengming Deng, Zhifang Wu, Yiwei Wu, Wei Zhang, Jihui Li, Na Dai, Bin Zhang, Jianhua Yan. Meta-Analysis of the Correlation between Apparent Diffusion Coefficient and Standardized Uptake Value in Malignant Disease. Contrast Media & Molecular Imaging 2017; 2017: 1 doi: 10.1155/2017/4729547
|
| 19 |
P. E. Tulin, M. B. Dolgushin, D. I. Nevzorov, P. V. Kochergin, Yu. I. Patyutko. PET/CT IN THE DIAGNOSIS OF PANCREATIC CANCER: LITERATURE REVIEW. Medical Visualization 2018; (1): 57 doi: 10.24835/1607-0763-2018-1-57-67
|
| 20 |
Haruna Kubota, Takeshi Sudo, Yosuke Shimizu, Naoto Hadano, Hirohumi Tazawa, Takahisa Suzuki, Takashi Onoe, Hirotaka Tashiro, Daiki Taniyama, Kazuya Kuraoka. Long-Term Survival after Pancreatic Resection for Metastasis from Colorectal Cancer: A Report of Two Cases. The Japanese Journal of Gastroenterological Surgery 2021; 54(9): 604 doi: 10.5833/jjgs.2020.0068
|
| 21 |
Kazuki Kobayashi, Takahiro Einama, Takazumi Tsunenari, Naoto Yonamine, Mikiya Takao, Yasuhiro Takihata, Hironori Tsujimoto, Hideki Ueno, Katsumi Tamura, Jiro Ishida, Yoji Kishi. Preoperative CA19‑9 level and dual time point FDG‑PET/CT as strong biological indicators of borderline resectability in pancreatic cancer: A retrospective study. Oncology Letters 2024; 27(6) doi: 10.3892/ol.2024.14412
|
| 22 |
Shigeo Koido, Junichi Taguchi, Masamori Shimabuku, Shin Kan, Tuuse Bito, Takeyuki Misawa, Zensho Ito, Kan Uchiyama, Masayuki Saruta, Shintaro Tsukinaga, Machi Suka, Hiroyuki Yanagisawa, Nobuhiro Sato, Toshifumi Ohkusa, Shigetaka Shimodaira, Haruo Sugiyama. Dendritic cells pulsed with multifunctional Wilms’ tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable conversion surgery in pancreatic cancer. Journal for ImmunoTherapy of Cancer 2024; 12(10): e009765 doi: 10.1136/jitc-2024-009765
|
| 23 |
Kaisa Ahopelto, Kapo Saukkonen, Jaana Hagström, Saila Kauhanen, Hanna Seppänen, Camilla Böckelman, Caj Haglund. TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT. Oncology 2021; 99(3): 177 doi: 10.1159/000510862
|
| 24 |
Jawaad Farrukh, Ravivarma Balasubramaniam, Anitha James, Sharan S Wadhwani, Raneem Albazaz. Pancreatic adenocarcinoma: imaging techniques for diagnosis and management. British Journal of Hospital Medicine 2022; 83(5): 1 doi: 10.12968/hmed.2022.0065
|
| 25 |
Mohamed Awali, Maria El Homsi, Tyler J. Fraum, Anup S. Shetty, Maria R. Ponisio, Karem Gharzeddine, Joyce Mhlanga, Nadine Mallak, Spencer Behr, Malak Itani. PET/MRI: pictorial review of hepatobiliary and pancreatic applications. Abdominal Radiology 2024; doi: 10.1007/s00261-024-04548-6
|
| 26 |
Quan-Jun Lin, Feng Yang, Chen Jin, De-Liang Fu. Current status and progress of pancreatic cancer in China. World Journal of Gastroenterology 2015; 21(26): 7988-8003 doi: 10.3748/wjg.v21.i26.7988
|
| 27 |
Makoto Takahashi, Hiroyuki Nojima, Satoshi Kuboki, Takuro Horikoshi, Tetsuo Yokota, Hideyuki Yoshitomi, Katsunori Furukawa, Tsukasa Takayashiki, Shigetsugu Takano, Masayuki Ohtsuka. Comparing prognostic factors of Glut-1 expression and maximum standardized uptake value by FDG-PET in patients with resectable pancreatic cancer. Pancreatology 2020; 20(6): 1205 doi: 10.1016/j.pan.2020.07.407
|
| 28 |
Ulrike Erb, Kun Zhao, Zhe Wang, Li Xiao, Margot Zöller. Murine and human pancreatic tumor exosome recovery in mouse serum: Diagnostic and prognostic potential and target cell delivery. Cancer Letters 2017; 403: 1 doi: 10.1016/j.canlet.2017.06.005
|
| 29 |
Elena Tabacchi, Cristina Nanni, Irene Bossert, Anna Margherita Maffione, Stefano Fanti. Nuclear Oncology. 2022; : 1 doi: 10.1007/978-3-319-26067-9_17-4
|
| 30 |
Erik V. Soloff, Mahmoud M. Al-Hawary, Terry S. Desser, Elliot K. Fishman, Rebecca M. Minter, Marc Zins. Imaging Assessment of Pancreatic Cancer Resectability After Neoadjuvant Therapy: AJR Expert Panel Narrative Review. American Journal of Roentgenology 2022; 218(4): 570 doi: 10.2214/AJR.21.26931
|
| 31 |
Li You, Feng Yang, De-Liang Fu. Prediction of malignancy and adverse outcome of solid pseudopapillary tumor of the pancreas. World Journal of Gastrointestinal Oncology 2018; 10(7): 184-193 doi: 10.4251/wjgo.v10.i7.184
|
| 32 |
Peter L. Qiao, Mahdusudhana Gargesha, Yiqiao Liu, Victoria E.A. Laney, Ryan C. Hall, Amita M. Vaidya, Hannah Gilmore, Kara Gawelek, Bryan B. Scott, Debashish Roy, David L. Wilson, Zheng-Rong Lu. Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis. Magnetic Resonance Imaging 2022; 86: 37 doi: 10.1016/j.mri.2021.11.008
|
| 33 |
Scott D. Haller, Karim Essani. Oncolytic Tanapoxvirus Variants Expressing mIL-2 and mCCL-2 Regress Human Pancreatic Cancer Xenografts in Nude Mice. Biomedicines 2024; 12(8): 1834 doi: 10.3390/biomedicines12081834
|
| 34 |
Carolin Zimmermann, Marius Distler, Christina Jentsch, Sophia Blum, Gunnar Folprecht, Klaus Zöphel, Heike Polster, Esther G. C. Troost, Nasreddin Abolmaali, Jürgen Weitz, Michael Baumann, Hans-Detlev Saeger, Robert Grützmann. Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial—PaCa-DD-041 (Eudra-CT 2009-011968-11). Strahlentherapie und Onkologie 2021; 197(1): 19 doi: 10.1007/s00066-020-01654-4
|
| 35 |
Chae Hong Lim, Young Seok Cho, Joon Young Choi, Kyung-Han Lee, Jong Kyun Lee, Ji Hye Min, Seung Hyup Hyun. Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography–based radiomics and genetic alterations of pancreatic ductal adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging 2020; 47(9): 2113 doi: 10.1007/s00259-020-04698-x
|
| 36 |
Nikhil Gupta, Raghav Yelamanchi. Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management. World Journal of Gastroenterology 2021; 27(23): 3158-3181 doi: 10.3748/wjg.v27.i23.3158
|
| 37 |
Zeyu Zhang, Guorong Jia, Guixia Pan, Kai Cao, Qinqin Yang, Hongyu Meng, Jian Yang, Lu Zhang, Tao Wang, Chao Cheng, Changjing Zuo. Comparison of the diagnostic efficacy of 68 Ga-FAPI-04 PET/MR and 18F-FDG PET/CT in patients with pancreatic cancer. European Journal of Nuclear Medicine and Molecular Imaging 2022; 49(8): 2877 doi: 10.1007/s00259-022-05729-5
|
| 38 |
Daniel Lew, Karl Kwok. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_29-1
|
| 39 |
Eleonora Rofi, Caterina Vivaldi, Marzia Del Re, Elena Arrigoni, Stefania Crucitta, Niccola Funel, Stefano Fogli, Enrico Vasile, Gianna Musettini, Lorenzo Fornaro, Alfredo Falcone, Romano Danesi. The Emerging Role of Liquid Biopsy in Diagnosis, Prognosis and Treatment Monitoring of Pancreatic Cancer. Pharmacogenomics 2019; 20(1): 49 doi: 10.2217/pgs-2018-0149
|
| 40 |
|
| 41 |
Bang-Bin Chen. PET-MRI of the Pancreas and Kidneys. Current Radiology Reports 2017; 5(8) doi: 10.1007/s40134-017-0229-5
|
| 42 |
Simone Krebs, Mark Dunphy. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 285 doi: 10.1016/B978-0-323-34062-5.00017-0
|
| 43 |
Robert Memba, Donal B. O’Connor, Kevin C. Conlon. Minimally Invasive Surgery of the Pancreas. Updates in Surgery 2018; : 75 doi: 10.1007/978-88-470-3958-2_8
|
| 44 |
Timothy Gilbert, Ryan Baron, Paula Ghaneh, Christopher Halloran. Pancreatic Cancer. 2018; : 753 doi: 10.1007/978-1-4939-7193-0_80
|
| 45 |
Constantin Ehrengut, Timm Denecke, Hans-Jonas Meyer. Benefits of Dual-Layer Spectral CT Imaging in Staging and Preoperative Evaluation of Pancreatic Ductal Adenocarcinoma. Journal of Clinical Medicine 2023; 12(19): 6145 doi: 10.3390/jcm12196145
|
| 46 |
Sampath Santhosh, Bhagwant Rai Mittal, Deepak Kumar Bhasin, Surinder Singh Rana, Rajesh Gupta, Ashim Das, Ritambhra Nada. Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma. Annals of Nuclear Medicine 2017; 31(8): 575 doi: 10.1007/s12149-017-1193-0
|
| 47 |
Wei Huang, Chenyi Liang, You Zhang, Di Zhang, Shuxian An, Qianyun Wu, Jiajin Li, Haitao Zhao, Cheng Wang, Jiujie Cui, Zhouzhou Bao, Gang Huang, Weijun Wei, Jianjun Liu. ImmunoPET imaging of Trop2 expression in solid tumors with nanobody tracers. European Journal of Nuclear Medicine and Molecular Imaging 2024; 51(2): 380 doi: 10.1007/s00259-023-06454-3
|
| 48 |
J. Gao, Y. Bai, F. Miao, X. Huang, M. Schwaiger, A. Rominger, B. Li, H. Zhu, X. Lin, K. Shi. Prediction of synchronous distant metastasis of primary pancreatic ductal adenocarcinoma using the radiomics features derived from 18F-FDG PET and MRI. Clinical Radiology 2023; 78(10): 746 doi: 10.1016/j.crad.2023.06.011
|
| 49 |
Randy Yeh, Laurent Dercle, Ishan Garg, Zhen Jane Wang, David M. Hough, Ajit H. Goenka. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma. Abdominal Radiology 2018; 43(2): 415 doi: 10.1007/s00261-017-1374-2
|
| 50 |
Leshuang Wu, Tianle Zou, Dan Shi, Huan Cheng, Muhammad Shahbaz, Muhammad Umar, Tianfeng Li, Xianbin Zhang, Peng Gong, Yushan Wei. Age in combination with gender is a valuable parameter in differential diagnosis of solid pseudopapillary tumors and pancreatic neuroendocrine neoplasm. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01164-7
|
| 51 |
Jihane Meziani, Gwenny M. Fuhler, Marco J. Bruno, Djuna L. Cahen, Kasper A. Overbeek. Pancreatic Cancer Screening: A Narrative Review. Techniques and Innovations in Gastrointestinal Endoscopy 2024; 26(4): 323 doi: 10.1016/j.tige.2024.08.001
|
| 52 |
Nathaniel E. Wiest, Varun P. Moktan, Sven P. Oman, Răzvan M. Chirilă. Screening for pancreatic cancer: a review for general clinicians. Romanian Journal of Internal Medicine 2020; 58(3): 119 doi: 10.2478/rjim-2020-0009
|
| 53 |
Elena Tabacchi, Cristina Nanni, Irene Bossert, Anna Margherita Maffione, Stefano Fanti. Nuclear Oncology. 2022; : 891 doi: 10.1007/978-3-031-05494-5_17
|
| 54 |
Ulrike Erb, Margot Zöller. Progress and potential of exosome analysis for early pancreatic cancer detection. Expert Review of Molecular Diagnostics 2016; 16(7): 757 doi: 10.1080/14737159.2016.1187563
|
| 55 |
T. Macarulla, T. Fernández, M. E. Gallardo, O. Hernando, A. M. López, M. Hidalgo. Adjuvant treatment for pancreatic ductal carcinoma. Clinical and Translational Oncology 2017; 19(10): 1199 doi: 10.1007/s12094-017-1683-5
|
| 56 |
Rakesh Kumar, Anshul Sharma, Pramod Garg, Raju Sharma, S. Datta-Gupta. Role of dual-point 18F-FDG-PET/CT in the diagnosis of pancreatic adenocarcinoma, in patients with and without concomitant chronic pancreatitis: Comparison with CECT and EUS. Pancreatology 2021; 21(4): 746 doi: 10.1016/j.pan.2021.02.011
|
| 57 |
Nandakumar Menon, Mark Mandelkern. Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors. Digestive Diseases and Sciences 2022; 67(10): 4633 doi: 10.1007/s10620-022-07616-3
|
| 58 |
Ik Jae Lee, Jinsil Seong. Innovation of Diagnosis and Treatment for Pancreatic Cancer. 2017; : 45 doi: 10.1007/978-981-10-2486-3_4
|
| 59 |
Lauren K. Park, Kian-Huat Lim, Jonas Volkman, Mina Abdiannia, Hannah Johnston, Zack Nigogosyan, Marilyn J. Siegel, Janet B. McGill, Alexis M. McKee, Maamoun Salam, Rong M. Zhang, Da Ma, Karteek Popuri, Vincent Tze Yang Chow, Mirza Faisal Beg, William G. Hawkins, Linda R. Peterson, Joseph E. Ippolito. Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study. Cancer & Metabolism 2023; 11(1) doi: 10.1186/s40170-023-00306-2
|
| 60 |
Nicholas McDonald, Syed Ahmad, Kyuran Ann Choe. Knowing Your Boundaries: A Review of the Definitions and Imaging Features of Borderline Resectable Pancreatic Carcinoma. Seminars in Roentgenology 2016; 51(2): 82 doi: 10.1053/j.ro.2016.02.001
|
| 61 |
Heying Duan, Lucia Baratto, Andrei Iagaru. The Role of PET/CT in the Imaging of Pancreatic Neoplasms. Seminars in Ultrasound, CT and MRI 2019; 40(6): 500 doi: 10.1053/j.sult.2019.04.006
|
| 62 |
Daniel Lew, Karl Kwok. Hepato-Pancreato-Biliary Malignancies. 2022; : 431 doi: 10.1007/978-3-030-41683-6_29
|
| 63 |
Xiaohui Zhang, Lisa Detering, Gyu Seong Heo, Deborah Sultan, Hannah Luehmann, Lin Li, Vikas Somani, Josie Lesser, Joan Tao, Liang-I. Kang, Alexandria Li, Divangana Lahad, Shinji Rho, Marianna B. Ruzinova, David G. DeNardo, Farrokh Dehdashti, Kian-Huat Lim, Yongjian Liu. Chemokine Receptor 2 Targeted PET/CT Imaging Distant Metastases in Pancreatic Ductal Adenocarcinoma. ACS Pharmacology & Translational Science 2024; 7(1): 285 doi: 10.1021/acsptsci.3c00303
|
| 64 |
Ali Zakaria, Bayan Al-Share, Jason B. Klapman, Aamir Dam. The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Cancer. Cancers 2022; 14(6): 1373 doi: 10.3390/cancers14061373
|
| 65 |
L. Wang, P. Dong, W.G. Wang, B.L. Tian. Positron emission tomography modalities prevent futile radical resection of pancreatic cancer: A meta-analysis. International Journal of Surgery 2017; 46: 119 doi: 10.1016/j.ijsu.2017.09.003
|